SEC – ‘UPLOAD’ from 1/21/22 re: Huntsman Corp., et al. – ‘TEXT-EXTRACT’

On:  Friday, 1/21/22, at 7:30am ET   ·   Delayed-Release:  Filing ¶  –  Release Delayed   ·   Accession #:  0-22-797

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Comment or Other Letter from the SEC   —   Delayed-Release

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: LETTER      Comment or Other Letter from the SEC                 PDF     27K 
 2: TEXT-EXTRACT  Comment or Other Letter from the SEC - PDF's         1      5K 
                Text                                                             

‘TEXT-EXTRACT’   —   Comment or Other Letter from the SEC – PDF’s Text

United States securities and exchange commission logo                           

January 20, 2022                      

Phil Lister                                                       
Chief Financial Officer                                           
Huntsman CORP                                                     
10003 Woodloch Forest Dr.                                         
The Woodlands, TX 77380                                           

                                            Re: Huntsman
Corporation                                                                     
                                                         Form 10-K for the
Fiscal Year Ended December 31, 2020                                             
                                                          Filed February 12,
2021                                                                            
                                                          File No. 333-85141
                                                Huntsman
International LLC                                                               
                                                         Form 10-K for the
Fiscal Year Ended December 31, 2020                                             
                                                          Filed February 12,
2021                                                                            
                                                          File No. 001-32427

Dear Mr. Lister:                                                  

            We have completed our review of your filings. We remind you that
the company and its                                                             
management are responsible for the accuracy and adequacy of their 
disclosures, notwithstanding                                                    
any review, comments, action or absence of action by the staff.   

Sincerely,                            

Division of Corporation Finance       

Office of Life Sciences               

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘UPLOAD’ Filing		Date		Other Filings
Filed on:		1/21/22		UPLOAD
		1/20/22		DFAN14A,  PREC14A,  UPLOAD
		2/12/21		10-K,  4,  8-K,  UPLOAD
		12/31/20		10-K,  5,  UPLOAD
				List all Filings